Optimal treatment for castration-resistant prostate cancer

Optimal treatment for castration-resistant prostate cancer

Bibliographic Details
Main Authors:	Kouji Izumi, Mikio Namiki
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2014-06-01
Series:	Asian Journal of Andrology
Online Access:	http://www.ajandrology.com/article.asp?issn=1008-682X;year=2014;volume=16;issue=3;spage=498;epage=498;aulast=Izumi

Similar Items

Understanding prostate-specific antigen dynamics in monitoring metastatic castration-resistant prostate cancer: implications for clinical practice
by: Atsushi Mizokami, et al.
Published: (2017-01-01)

TAXANES IN THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER
by: T. N. Skvortsova, et al.
Published: (2017-01-01)

Treatment sequencing in metastatic castrate-resistant prostate cancer
by: Oliver Sartor, et al.
Published: (2014-06-01)

Radium-223 for the treatment of castration-resistant prostate cancer
by: El-Amm J, et al.
Published: (2015-05-01)

The resurgence of estrogens in the treatment of castration-resistant prostate cancer
by: H Krishna Moorthy, et al.
Published: (2019-01-01)

Castration-Resistant Prostate Cancer: Mechanisms, Targets, and Treatment
by: Teresa Maria Santos Amaral, et al.
Published: (2012-01-01)

Enzalutamide for the treatment of metastatic castration-resistant prostate cancer
by: Rodriguez-Vida A, et al.
Published: (2015-06-01)

State-Of-The-Art Treatment in Castration-Resistant Prostate Cancer
by: Elena Castro, et al.
Published: (2014-11-01)

New developments in the treatment of castration resistant prostate cancer
by: Roxanne Wadia, et al.
Published: (2014-08-01)

Abiraterone in the treatment of metastatic castration-resistant prostate cancer
by: Mostaghel EA
Published: (2014-01-01)

Darolutamide For Castration-Resistant Prostate Cancer
by: Bastos DA, et al.
Published: (2019-10-01)

Determine of the optimal number of cycles of docetaxel in the treatment of metastatic castration-resistant prostate cancer
by: Yuan-Chi Shen, et al.
Published: (2016-09-01)

The role of cabazitaxel in the treatment of metastatic castration-resistant prostate cancer
by: Che-Kai Tsao, et al.
Published: (2014-06-01)

Androgen synthesis inhibitors in the treatment of castration-resistant prostate cancer
by: Mark N Stein, et al.
Published: (2014-06-01)

The changing landscape in the treatment of metastatic castration-resistant prostate cancer
by: Joelle El-Amm, et al.
Published: (2013-01-01)

Update on options for treatment of metastatic castration-resistant prostate cancer
by: Prakash Vishnu, et al.
Published: (2010-03-01)

Clinical Development of Cabazitaxel for the Treatment of Castration-Resistant Prostate Cancer
by: Che-Kai Tsao, et al.
Published: (2011-01-01)

Supraphysiological Testosterone Therapy as Treatment for Castration-Resistant Prostate Cancer
by: Hung-Ming Lam, et al.
Published: (2018-05-01)

A changing landscape in castration resistant prostate cancer treatment
by: Alessandra eFelici, et al.
Published: (2012-07-01)

Experience with octreotide depot in the treatment of castration-resistant prostate cancer
by: G. P. Kolesnikov
Published: (2015-06-01)

Optimal usage of radium-223 in metastatic castration-resistant prostate cancer
by: Tai-Lung Cha, et al.
Published: (2017-11-01)

Impact of Time to Castration Resistance on Cytoreductive Radiotherapy in Metastatic Castration-Resistant Prostate Cancer
by: Lixin Mai, et al.
Published: (2020-12-01)

Enzalutamide versus abiraterone as a first-line endocrine therapy for castration-resistant prostate cancer (ENABLE study for PCa): a study protocol for a multicenter randomized phase III trial
by: Kouji Izumi, et al.
Published: (2017-10-01)

Editorial: Response and Resistance in Castration-Resistant Prostate Cancer
by: Renée de Leeuw, et al.
Published: (2020-10-01)

Reappraisal of glucocorticoids in castrate-resistant prostate cancer
by: Oliver Sartor, et al.
Published: (2014-10-01)

Chemotherapy options in castration-resistant prostate cancer
by: Benjamin A Teply, et al.
Published: (2016-01-01)

Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer
by: Jingsong Zhang, et al.
Published: (2017-11-01)

The Current Landscape of Treatment in Non-Metastatic Castration-Resistant Prostate Cancer
by: Joelle El-Amm, et al.
Published: (2019-02-01)

The role of radiation therapy in the treatment of metastatic castrate-resistant prostate cancer
by: Jim N. Rose, et al.
Published: (2015-06-01)

Physician preferences for non-metastatic castration-resistant prostate cancer treatment
by: Sandy Srinivas, et al.
Published: (2020-06-01)

Clinical use of abiraterone in the treatment of metastatic castration-resistant prostate cancer
by: Zobniw CM, et al.
Published: (2014-08-01)

A profile of enzalutamide for the treatment of advanced castration resistant prostate cancer
by: Greasley R, et al.
Published: (2015-06-01)

Oral etoposide and oral prednisone for the treatment of castration resistant prostate cancer
by: Yi-Ping Zhu, et al.
Published: (2014-02-01)

Cost-effectiveness analysis of treatments for metastatic castration resistant prostate cancer
by: Matthew E. Pollard, et al.
Published: (2017-01-01)

Treatment of non-metastatic castration-resistant prostate cancer: focus on apalutamide
by: Gul A, et al.
Published: (2019-08-01)

Radium-223 in treatment of castration-resistant prostate cancer with skeletal metastases
by: V. B. Matveev, et al.
Published: (2017-10-01)

Somatostatin analogs in the treatment of castrate-resistant prostate cancer: efficacy and tolerability
by: G. P. Kolesnikov, et al.
Published: (2016-09-01)

Resolution on the results of the Meeting of Experts on the treatment of castrate-resistant prostate cancer
by: B. Ya. Alekseev, et al.
Published: (2016-09-01)

The new approaches to the treatment of castration- resistant prostate cancer: PARP inhibitors
by: А. А. Gritskevich, et al.
Published: (2021-06-01)

Adaptive pathways and emerging strategies overcoming treatment resistance in castration resistant prostate cancer
by: Cameron M. Armstrong, et al.
Published: (2016-10-01)